Comparison among natural (Arg 304Gln, Arg 304Trp) and artificial (Arg 290His, Arg 290Lys) mutations in coagulation factor VII loops

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2455-2457

  Furlan Freguia, C ^a   Toso, R ^a   Pinotti, M ^a   Gemmati, D ^a   Bernardi, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

AMINO ACID SEQUENCE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; COMPARATIVE STUDY; GENETICS; HUMAN; LETTER; MISSENSE MUTATION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; FACTOR VII; FACTOR VII DEFICIENCY; HUMANS; MUTATION, MISSENSE; SEQUENCE ALIGNMENT;

EID: 4444370350     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.0468e.x     Document Type: Letter

References (12)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade. Initiation, Maintenance, Regulation Biochem 1991; 30: 10363-70.
2. Pike ACW, Brzozowsk AM, Roberts SM, Olsen OH, Persson E. Structure of human factor Vila and its implications for the triggering of blood coagulation. Proc Natl Acad Sci USA 1999; 96: 8925-30.
3. Kemball-Cook G, Johnson DJD, Tuddenham EGD, Harlos K. Crystal structures of active site-inhibited human coagulation Factor Vila (dea- Gla). J Structural Biol 1999; 127: 213-23.
4. Jin J, Perera L, Stafford D, Pedersen L. Four loops of the catalytic domain of factor Vila mediate the effect of the first EGF-like domain substitution on factor Vila catalytic activity. J Mol Biol 2001; 307: 1503-17.
5. Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation factor VII mutation (A294V, cl52) in loop 140s affects the interaction with activators, tissue factor and substrate. Biochem J 2002; 363: 411-6.
6. Marchetti G, Patracchini P, Gemmati D, DeRosa V, Pinotti M, Rodorigo G, Casonato A, Girolami A, Bernardi F. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum Genet 1992; 89: 497-502.
7. FVII mutation database, http://www.europium.csc.mrc.ac.uk/. Accessed June 2003.
8. O'Brien DP, Gale K, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EGD. Purification and characterization of FVII 304 Gin: a variant molecule with reduced activity isolated from a clinically un affected male. Blood 1991; 78: 132-40.
9. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304 (r) Trp). J Biol Chem 1994; 269: 7355-63.
10. Bernardi F, Liney DL, Petracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Radaelli R, Bakkerini G, Pemberton S, Wacey AI, Mariani GM, Tuddenham EGD, Marchetti G. Molecular defects in CRM+ factor VII deficiencies, modelling of missense mutation in the catalytic domain of FVII. Br J Haematol 1994; 86: 610-8.
11. Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000; 84: 250-7.
12. Ruf W. Factor Vila residue Arg290 is required for efficient activation of the macromolecular substrate factor X. Biochemistry 1994; 33: 11631-6.